The importance of the new prognostic scoring system for evaluating patients with lower-risk myelodysplastic syndrome at diagnosis

The importance of the new prognostic scoring system for evaluating patients with lower-risk myelodysplastic syndrome at diagnosis

Sindroamele mielodisplazice (SMD) reprezintă un grup heterogen de hemopatii clonale ale celulei stem caracterizate prin hematopoieză ineficientă cu afectarea uneia sau mai multor linii mieloide şi risc crescut de transformare în leucemie acută. Diagnosticul curent include morfologia sângelui perifer...

Full description

Bibliographic Details
Main Authors: Tatic Aurelia, Jardan Cerasela, Georgescu Otilia, Stanca Oana, Vasilica Madalina, Badelita Sorina, Crisan Ana Manuela, Colita Adriana, Colita Dan, Vulcan Genica, Lupu Anca Roxana, Iosif Ionel, Coriu Daniel
Format: Article
Language:English
Published: Sciendo 2013-09-01
Series:Romanian Journal of Laboratory Medicine
Subjects:
myelodisplastic syndromes
international prognostic scoring system (ipss)
revised international prognostic scoring system (r-ipss)
sindroame mielodisplazice
sistemul de scor prognostic internaţional (ipss)
sistemul de scor prognostic internaţionalrevizuit (ipss-r)
Online Access:https://doi.org/10.2478/rrlm-2013-0033

Internet

https://doi.org/10.2478/rrlm-2013-0033

Similar Items